—
Most of us know someone who has been pulled into the long, confusing world of the American healthcare system. We have seen a parent shuttling between specialists or a friend waiting weeks for answers that never seem to come. We talk about these experiences in broad terms, focusing on the illness itself, but there’s a quieter problem underneath it all that rarely gets named. Diagnostic errors contribute to nearly 10 percent of patient deaths in the United States, according to the National Academies of Sciences, Engineering, and Medicine, and they shape how quickly someone gets the right care. If we could fix this one issue, families would face fewer delays, fewer wrong turns and far less financial strain. That is the problem Yu-Han Tsai has dedicated her career to solving.
Tsai works as a molecular technologist, handling the kind of genetic data that forms the backbone of precision medicine. She spends her days processing DNA and RNA from countless patient samples and making sure the information feeding AI models is as accurate as possible. “My job is actually to be at the forefront of the future of medical care,” she said. Her role may sound technical, but the impact is easy to understand. When doctors have clearer information earlier, patients spend less time navigating uncertainty and more time receiving the right treatment.
A big reason for diagnostic mistakes is volume. By the time someone reaches a specialist, they may have years of complex medical history behind them, including images, lab results, scans, and repeated tests. Even the best clinicians can only review so much. Tsai sees this problem every day in the lab. “This is a heartbreaking statistic and reveals the great challenges facing modern medicine,” she said. She points to two issues in particular. The first is the overwhelming amount of data. The second is inconsistency. When testing processes vary from one hospital to another, results can shift. Standardization, automation and rigorous quality control help close those gaps and give patients answers they can trust.
Advances in DNA and RNA sequencing, paired with AI, are offering a way forward. Tsai says these tools are already transforming diagnosis for everyday families. “It’s not futuristic, it’s ongoing now, and it will ultimately save money for families.” Instead of waiting weeks for clarity, high-throughput sequencing can generate massive datasets in days. AI then searches through billions of data points in minutes, identifying disease markers and narrowing treatment options. Families save money when they avoid unnecessary medications, repeated scans and emergency room visits tied to trial and error.
These technologies also help shorten the long and frustrating process many patients endure when trying one treatment after another. In cancer care, for example, AI can analyze a tumor’s genetic makeup and help physicians understand which drugs will work and which will not. Patients avoid harsh treatments with little benefit, and the health system avoids costs tied to those ineffective approaches. Similar gains are happening in psychiatry and chronic pain management, where matching the right drug to a patient’s genetic profile can shorten suffering and lead to more stable recovery.
But none of this progress works without a trained workforce behind it, and that is where Tsai plays another crucial role. As a Designated Trainer, she helps close one of the biggest talent gaps in American biotechnology. “Our greatest shortage is battle tested translation professionals,” she said. These are the people who understand both the science and the clinical environment. Tsai trains new technologists to meet strict CAP and CLIA standards and ensures they can handle a wide range of molecular testing procedures within just a few months. Her work directly strengthens the U.S. bioscience sector, which generates more than $3.2 trillion in annual economic output, according to industry analysis from the Biotechnology Innovation Organization.
If AI powered diagnostics became standard in hospitals across the country, the effect would reach far beyond individual patients. Millions could receive accurate answers earlier each year. Tens of thousands of lives could be saved by reducing diagnostic errors. Billions of dollars could be redirected from waste to prevention and early treatment. And a healthier workforce means a stronger economy.
Tsai is also helping close the gap between major hospitals and smaller clinics by supporting cloud based diagnostic models that give community hospitals access to the same advanced analysis as large medical centers. For families in rural or underserved areas, this could mean faster diagnoses without needing to travel far from home.
Diagnostic errors should be part of the conversation because they shape the lives of patients and families every day. Tsai’s work is pushing the country toward a system where clarity, accuracy and equity are within reach for everyone. Solving this problem would not just save lives. It would ease the burden on millions of American families and build a healthcare system that works faster and smarter for all of us.
—
This content is brought to you by Melissa Moraes.
Photo provided by the author.
